Fulgent GeneticsFLGT
Market Cap: 708M
About: Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Employees: 1,012
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
2,012% more call options, than puts
Call options by funds: $47.2M | Put options by funds: $2.24M
1.28% more ownership
Funds ownership: 48.27% [Q4 2023] → 49.55% (+1.28%) [Q1 2024]
9% less funds holding
Funds holding: 192 [Q4 2023] → 174 (-18) [Q1 2024]
18% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 60
22% less capital invested
Capital invested by funds: $414M [Q4 2023] → $321M (-$92.4M) [Q1 2024]
41% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 44
Research analyst outlook
1 Wall Street Analyst provided 1 year price forecasts over the past 6 months
1 analyst rating
Piper Sandler David Westenberg | 6%upside $25 | Neutral Maintained | 6 Mar 2024 |